The director of the Chumakov center spoke about the work on a vaccine against the delta strain of coronavirus

“First of all, this is not a modification (of the vaccine -

), it is the creation of a new vaccine.

In fact, the coronavirus is a young virus, but, as you know, it is quite actively spreading around the globe.

During this propagation, it mutates.

The world medical community now knows both "alphas" and "deltas" and already other names, "Ishmukhametov said, adding that scientists were faced with the question of studying these strains.

After the introduction of the "delta" strain, which actually supplanted other strains, it became necessary to find out "what it is," he said.

In this situation, the Chumakov center “went the same way”, isolating the “delta” strain, which is now the basis for creating a vaccine.

“Then you need to go all the way that we went with the previous strain - with the“ alpha ”strain.

That is, to learn how to cultivate it, grow, “pass through” at least seven times in order to achieve a certain stability of the life of this strain, after which it can be the basis, ”said the director of the center.

At the same time, Ishmukhametov admitted that it could be a combination of two strains in one preparation.

“I say it again: the virus is new, it is young, it is growing and changing, it has not yet reached its final stable form, so all actions are aimed at controlling its new changes,” he stressed.

According to Ishmukhametov's estimates, a vaccine against the delta strain can be expected in about a year.

Earlier, Georgy Vikulov, director of the Research Center for the Prevention and Treatment of Viral Infections, commented on reports that the Chumakov Center plans to change the KoviVac vaccine for the delta strain.

Then he noted that the new version can be combined, that is, contain two components at once.